realistic expectations, page-38

That 2.8 million doesn't include the underwriters fee's, or any of the general/ admin expenses incurred. From memory alot of the 2.8 is actually legal fees...

"Some posters were valuing ACL (fonda) at around 30c post split. Given that, do we now have a market value of the oncology program of around 8c?"

Yeah good point. Think I was one of those posters, however that was under the assumption that Fonda revenues were gong to be returned to holders, rather than used to partially fund our oncology platform. You also have the real threat of a CR that needs to be factored in.